LU45106A1 - - Google Patents

Info

Publication number
LU45106A1
LU45106A1 LU45106DA LU45106A1 LU 45106 A1 LU45106 A1 LU 45106A1 LU 45106D A LU45106D A LU 45106DA LU 45106 A1 LU45106 A1 LU 45106A1
Authority
LU
Luxembourg
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU45106A1 publication Critical patent/LU45106A1/xx

Links

LU45106D 1962-12-27 1963-12-23 LU45106A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP5741963 1963-10-29
JP6427663 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
LU45106A1 true LU45106A1 (cg-RX-API-DMAC7.html) 1964-02-24

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
LU45106D LU45106A1 (cg-RX-API-DMAC7.html) 1962-12-27 1963-12-23

Country Status (5)

Country Link
BE (1) BE641880A (cg-RX-API-DMAC7.html)
FR (1) FR3150M (cg-RX-API-DMAC7.html)
GB (1) GB1080599A (cg-RX-API-DMAC7.html)
LU (1) LU45106A1 (cg-RX-API-DMAC7.html)
NL (1) NL302572A (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
MX2007006171A (es) 2004-11-26 2007-10-08 Ucl Business Plc Composiciones que comprenden ornitina y acetato.
EP3263100B1 (en) 2009-04-03 2020-04-01 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
KR101715008B1 (ko) 2009-06-08 2017-03-22 유씨엘 비즈니스 피엘씨 L―오르니틴 페닐아세테이트를 사용한 문맥압 항진증의 치료 및 간 기능 회복
EP2625162B1 (en) 2010-10-06 2019-03-13 Ocera Therapeutics, Inc. Methods of making l-ornithine phenyl acetate
CA2968544A1 (en) 2014-11-24 2016-06-02 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
EP3337473A4 (en) 2015-08-18 2019-04-17 Ocera Therapeutics, Inc. TREATMENT AND PREVENTION OF MUSCLE WOUND BY L-ORNITHIN IN COMBINATION WITH AT LEAST ONE PHENYL ACETATE AND PHENYL BUTYRATE
AU2018266357B2 (en) 2017-05-11 2022-12-08 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
GB1080599A (en) 1967-08-23
FR3150M (fr) 1965-02-22
BE641880A (cg-RX-API-DMAC7.html) 1964-04-16
NL302572A (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
BE616548R (cg-RX-API-DMAC7.html)
BE614432A (cg-RX-API-DMAC7.html)
BE614403A (cg-RX-API-DMAC7.html)
BE635240A (cg-RX-API-DMAC7.html)
BE634821A (cg-RX-API-DMAC7.html)
BE633765A (cg-RX-API-DMAC7.html)
BE633687A (cg-RX-API-DMAC7.html)
BE633210A (cg-RX-API-DMAC7.html)
BE632887A (cg-RX-API-DMAC7.html)
BE632633A (cg-RX-API-DMAC7.html)
BE614380A (cg-RX-API-DMAC7.html)
BE629169A (cg-RX-API-DMAC7.html)
BE628347A (cg-RX-API-DMAC7.html)
BE627004A (cg-RX-API-DMAC7.html)
BE626971A (cg-RX-API-DMAC7.html)
BE621553A (cg-RX-API-DMAC7.html)
BE620644A (cg-RX-API-DMAC7.html)
BE620399A (cg-RX-API-DMAC7.html)
BE616785A (cg-RX-API-DMAC7.html)
BE616490A (cg-RX-API-DMAC7.html)
BE616386A (cg-RX-API-DMAC7.html)
BE616166A (cg-RX-API-DMAC7.html)
BE615962A (cg-RX-API-DMAC7.html)
BE641880A (cg-RX-API-DMAC7.html)
BE615849A (cg-RX-API-DMAC7.html)